Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy

Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy

The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has received significant attention as a cancer therapeutic due to its ability to selectively trigger cancer cell apoptosis without causing toxicity in vivo. While TRAIL has demonstrated significant promise in preclin...

Full description

Bibliographic Details
Main Authors: Guimarães, Pedro P.G (Author), Gaglione, Stephanie (Author), Sewastianik, Tomasz (Author), Carrasco, Ruben D. (Author), Langer, Robert S (Author), Mitchell, Michael J. (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2021-03-15T12:43:27Z.
Subjects:
Article
Online Access:Get fulltext

Similar Items

Similar Items